Almac Group is proud of its global reputation for excellence, delivering expertise right across the drug development lifecycle and offering a tailored solution to each client.
Our client relationships are long term and they are underpinned by one simple commitment:
We will be exceptional, always.
Latest from Almac
February 18th, 2020
Almac Clinical Services’ Just in Time Manufacturing Operations Pass EU Regulatory Inspection
January 08th, 2020
Galen, an Almac company, announces completion of multi-million pound POA Pharma acquisition
October 21st, 2019
Almac Group £35 million Brexit Solution Complete with EU distribution center attaining successful HPRA inspection
Almac Brexit Resource Hub
Partnering to advance human healthExplore our locations
Almac recognizes that you need bespoke solutions to suit your needs. Only we can combine the expertise from our world leading range of specialized drug development services to support you across the full biopharmaceutical product lifecycle, from the preclinical stages through to commercialization.
Almac Diagnostic Services is our stratified medicine business unit, specializing in biomarker driven clinical trials. Our global laboratories, in the UK and US, offer tailored solutions from discovery to commercialization: biomarker discovery, assay development & validation, CDx development & commercialization. Your clinical trial diagnostic partner.
Almac Discovery is an independent, research driven drug discovery company dedicated to the development of novel and innovative therapeutics. Our multidisciplinary team of scientists use cutting edge research techniques to develop First in Class preclinical stage assets. Key research themes include protein homeostasis (specifically focused on deubiquitinase enzymes) and next generation protein drug conjugates.Find out more